Rhumbline Advisers Purchases 1,485 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Rhumbline Advisers boosted its position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) by 6.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 25,143 shares of the biotechnology company’s stock after acquiring an additional 1,485 shares during the period. Rhumbline Advisers’ holdings in Rigel Pharmaceuticals were worth $423,000 at the end of the […]
Rhumbline Advisers boosted its position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) by 6.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 25,143 shares of the biotechnology company’s stock after acquiring an additional 1,485 shares during the period. Rhumbline Advisers’ holdings in Rigel Pharmaceuticals were worth $423,000 at the end of the […]
